NVO20260702C38.5
NVO Jul 2 2026 38.50 Call (NVO260702C00038500)
option OPRA

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.